G406-1695 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

G406-1695 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide
G406-1695 Screening compound: 2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G406-1695
2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G406-1695

Molecular Formula

C27H33N3O4S (C27 H33 N3 O4 S)

Compound Name

2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1,2,3,4-tetrahydroquinolin-1-yl}-N-(1,2,3,4-tetrahydronaphthalen-1-yl)acetamide

IUPAC name

2-{6-[(4-methylpiperidin-1-yl)sulfonyl]-2-oxo-1234-tetrahydroquinolin-1-yl}-N-(1234-tetrahydronaphthalen-1-yl)acetamide

SMILES

CC(CC1)CCN1S(c(cc1)cc(CC2)c1N(CC(NC(CCC1)c3c1cccc3)=O)C2=O)(=O)=O

InChI

InChI=1S/C27H33N3O4S/c1-19-13-15-29(16-14-19)35(33,34)22-10-11-25-21(17-22)9-12-27(32)30(25)18-26(31)28-24-8-4-6-20-5-2-3-7-23(20)24/h2-3,5,7,10-11,17,19,24H,4,6,8-9,12-16,18H2,1H3,(H,28,31)/t24-/m0/s1

InChI Key

KTOQALYEECLTDO-DEOSSOPVSA-N

MDL Number (MFCD)

MFCD27139364

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

495.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

4.417

Distribution Coefficient, logD

4.417

Water Solubility, LogSw

-4.18

Polar Surface Area

71.645

Acid Dissociation Constant (pKa)

12.01

Base Dissociation Constant (pKb)

-1.13

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

48.10

G406-1695 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G406-1695 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G406-1695?
Check Price and Availability of G406-1695, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G406-1695 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G406-1695
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G406-1695
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G406-1695 available by request